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2, 3-Diphenyl- 5-methoxyindole-6-carboxaldehyde
2b is reacted with semicarbazide hydrochloride to give
the corresponding semicarbazide derivative 3 which is
cyclized to the triazole 4. The chalcones Sa and 5b
have been prepared from the 5-hydroxy- and 5-me-
thoxyindole derivatives 2a and 2b respectively by
treatment with jraminoacetophenone and these are
then cyclized with hydrazine hydrate to 6a and '6b re-
spectively. 5-Chloro-2, 3-diphenylindole 7 is convert-
ed into the 6-amino derivative 8 by nitration followed
by reduction and the amino derivative is then con-
densed with salicylaldehyde to give the benzoxazepi-
nyl derivative 9. Compound 8 on treatment with ace-
tonitrile, ethyl isothiocyanate and o-chlorophenol
yields 10, II and 12 respectively. Compounds Ia, b;
3; 4; Sa, b and 6a, b have been tested for their an-
tiinflammatory and analgesic activities. Compounds la
and 3 are found to be the more potent antiinflamma-
tory compounds as compared to indomethacin and 3
and 5b have been found to be more potent than aspir-
in.
Sulindac and indomethacin, both indole acetic
acid derivatives are used as antiinflammatory
agent in therapy'. A considerable amount of work
has been done on the structural variation of the
class of drugs broadly known as non-steroidal an-
tiinflammatory drugs (NSAIDS)2-9. It has been ob-
served that the best known non-steroidal antiin-
flammatory drugs (NSAIDS) are acidic in nature.
In view of this our attention has been directed on
the variation of the aromatic indole moiety by in-
troducing different acidic function groups and
cyclization to form 5, 6- and 7-membered hetero-
cyclic ring with a view to synthesize new anal-
ogues with improved analgesic'S" and antiin-
flammatory effect.
Note
Formylation of 2, 3-diphenyl-5-hydroxy- or me-
thoxyindole la, b gave the 6-carhoxaldehyde de~
rivatives 2a, bI2 (Scheme I). 2, 3-Diphenyl-
5-methoxy-6-carboxaldehyde 2b was reacted with
semicarbazide in acetic acid to form the corre-
sponding semicarbazone derivative 3 which on
cyclization with ferric chloride hexahydrate gave
the corresponding 1, 3, 4-triazole derivative 4.
On the other hand, compounds 2a, b were treat-
ed with p-arninoacetophenone in 10% sodium hy-
droxide to yield the chalcones 5a, b which were
cyclized with hydrazine hydrate to produce the
pyrazoline derivatives 6a, b. .
Nitration of 5-chloro-2, 3-diphenylindole by
cone. nitric and sulphuric acid mixture (1:1) fol-
lowed by reduction using cone. hydrochloric acid
and granulated tin afforded the 6-aminoindole
derivative 8 which on condensation with salicy-
laldehyde in dry benzene furnished benzoxazepi-
nyl derivative 9.
Imidazole derivatives 10 and 11 were prepared
by the reaction of 8 with acetonitrile and ethyl
isothiocyanate in the presence of sodium. hydride.
Cyclization of 8 with o-chlorophenol in the pres-
ence of sodium hydride gave the benzomorpholi-
nyl derivative 12.
Pharmacological studies
The pharmacological tests were conducted on
male albino rats weighing (120-150 g) and the
animals were obtained from the Animal House
Colony, N.R.C., Cairo, Egypt. They were housed
6 per cage and fed on standard laboratory diet.
Water was given ad libitum
Anti-inflammatory effect
Six rats in each group: Group 1 control re-
ceived 0.5 mL of 20% propylene glycol in water
intraperitoneally and then injected subcutaneous
with 0.1 of 5% sterile formalin solution in saline
into the right hind paw and acts as positive con-
trol. Group 2 received indomethacin 20 mg!kg b.
wt. as positive control. Group 3-10 received the
tested compounds which are la, b; 3; 4; 5a, b;
6a, b in 10 mg/kg, b. wt. in 20% propylene glycol.
The acute anti-inflammatory effect were measured
according to Winter et at.13, the mean percent oe-
dema was calculated and compared with that of
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Scheme I
Table I-Physical and spectral data of compounds prepared
Compd m.p.(°C) Yield Mol. formula Analysis calcd/(Found) IR (KBr) (cm-1) Mass IHNMR
solvent for (%) spectra (l'J inppm)
crystallization C H N (m/z)
la 145 60 C2oH1SN 89.21 5.58 5.20 3400 (OH), 3310 8.15 (s, lH, NH
acetone (269.259) (89.11 5.49 5.09) (NH) exchangeable
D2O),7.45-6.75
(m, 13H, Ph, Hs)
Ib 120 70 C21Hl1NO 84.25 5.71 4.67 330.0 (NH)
ethanol (299.334) (84.11 5.51 4.54)
2a 178-179 'C21HlS02N 80.49 4.82 4.47 3450-3300 (OH,
Ethanol (313.314) (80.35 4.71 4.39) NH), 1680 (CHO)
2b 190 C22Hl103N 76.95 4.98 4.07 3320 (NH), 1690 10.5 (s, lH,
ethanol (343.336) (76.89 4.90 4.00) (CHO) CHO),8.55
(s, lH, NH), 7.95-
7.05 (m, 12H, Ph,
Hs), 4.0 (s, 3H,
OCH3)
3 70 dec. 50 C23H20N402 71.86 5.24 14.57 3400-3300 (NH2,
methanol (384.437) (71.76 5.19 14.41) NH),1671(-CO-
3534 NH),1620(C=N)
4 130 50 C23H18N402 72.24 4.74 14.65 \(OH),3426 382
methanol (382.423) (72.13 4.69 14.58) (NH),1630(C=N) (Mol.wt)
5a 190 60 C29H22N202 80.91 5.15 6.51 3570 (OH), 3400-
ethanol (430.482) (80.87 5.05 6.43) 3300 (NH2, NH),
171O(C=O)...• 5b 210 dee. 65 C30H24N202 81.06 5.44 6.30 3480-3306 (broad 444.5
ethanol (444.508) (81.00 5.37 6.26) NH2, NH, 1720 (Mol.wt)
(C=O)
6a 195 60 C29H24N40 78.35 5.44 12.61 3580-3310 (broad, 444.5
methanol (444.514) (78.29 5.40 12.49) OH, NH2, NH), (Mol.wt)
161O(C=N) -Contd.
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55 C30Hz6N40 78.58 5.72
(458.54) (78.48 5.69
60 CZOHI4NCI 79.07 4.65
(303.777) (79.00 4.55
70 CzoHIsN2Cl 75.35 4.74
(318.793) (75.28 4.67
75 C27H1SNzO 83.91 4.70
(386.43) (83.89 4.55
60 C22H17N3 81.71 5.30
(323.38) (81.69 5.25







8.79 3460-3320 (NH2' NH)
8.69)
7.25 3391 (NH), 1600
7.15) (C=N)
13.00 3372 (NH), 1604
12.90) (C=N)
11.37 3356 (NH, 1640
11.29) (C = N)
12 above 250 60 CZ6HISN20 83.40 4.85 7.48 3397 (broad NH)
acetone (374.42)(83.35 4.75 7.39)
dec. = decomposition. Cl and S analysis: 7: Cl, 11.67 (11.60); 8: CI, 11.12 (11.00); II: S, 8.68 (8.55).
386 8.2(s,IH,CH=
















Table Il-Anti-inflammatory activity of indomethacin and the tested compounds compared with control positive group
Compd 30min 60min 90min 120 min
Control +ve A· 100.4±2.1 A 106.8 ±3.1 AC 118.74 ± 5.8 AC 122.32 ± 6.32
la D 129.17±7.79 BC 101±2.12 B 97.3 ± 3.13 B 67 ±4.53
Ib A 113.83 ± 6.93 A 75.3 ± 1.94 A 72.83 ± 3.70 AC 96.7 ± 5.58
3 B 63±2.76 A 70 ±2.89 A 72.3 ± 2.12 B 72±2.05
4 CE 101.7 ±2.4 A 74.2 ± 2.79 BC 105.8 ±2.98 A 100.7 ± 3.45
Sa B 72 ± 1.37 A 74.33 ± 1.65 B 97.3±2.6 AC 96.2 ± 1.66
Sb AC 103.2 ±4.09 C 110.5 ±5.56 C 198.83 ± 5.66 , A 98.3 ±3.07
6a B 73.2 ±3.9 A 71±3.54 A 72.7±2.1 A 98.3 ± 1.69
6b CE 99.3 ± 1.98 B 97.83 ± 1.8 B 97 ±2.45 A 98.3 ±3.33
Indomethacin E 91.17 ±3.27 A 77.17 ± 1.70 A 83.17±3.66 C 86 ±3.43
A, B, C, D, E, F: Means in each row not showing a common letter differ significantly (P< 0.05).
using analysis variance and least significant differ-
ence test" (cf. Table II).
Compounds la, b had acute antiinflammatory
effect. Substitution of 1b in position-S by a semi-
carbazone group i.e. compound 3 improved the
antiinflammatory activity through acute action.
Compound 3 was more potent than indomethac-
in. Unfortunately cyclization of 3 with ferric chlo-
ride to obtain 4 abolished the effect.
Chalcone Sa showed an acute antiinflammatory
effect while no effect was observed in the case of
5b.
The pyrazoline derivative 6a possesses an acute
antiinflammatory activity while compound 6b
does show any activity.
It is important to note that compounds la and
3 were the most potent antiinflammatory com-
pounds in comparison to indomethacin.
Analgesic activity
It was investigated using the hot plate method".
The tested compounds la, b; 3; 4; 5a, b; 6a, b
were given to mice at a dose level of 10 mg!
kg.The mean reaction time of control, aspirin-
treated mice and the tested compounds were cal-
culated using analysis of variance and least signifi-
cant difference (cf.Table ill).
The starting material 1a had significant analges-
ic effect resembling aspirin while the 5-methoxy
derivatives la had significant effect compared to
aspirin. Condensation of 2a with semicarbazide
hydrochloride gave the schiff's base 3 which is
more potent than aspirin. Cyclization with ferric
chloride yielded compound 4 which did not show
any analgesic activity.
Chalcone 5a. was devoid of any analgesic effect
while 5b had significant analgesic effect and was
more potent than aspirin. The pyrazoline deriva-
tives 6a, b failed to show any analgesic effect.
Finally, we conclude that compounds 3 and 5
were potent compounds than aspirin due to the
free methoxy in position-5, ortho to the unsaturat-
ed amide side chain. Moreover, compound 3 was
the most potent antiinflammatory and analgesic
compound compared to the positive control.
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Experimental Section
All m.ps are uncorrected. The IR spectra
were recorded in KBr on a Unicam SP 200 spec-
trophotometer and IH-NMR spectra in CDCl3 or
DMSO using a Geol DFF 100 (270 MHz) with
TMS as an internal reference.
2, 3-Diphenylindole-6-carboxaldehyde deriva-
tives 2a, b16• Phosphorous oxychloride (2 mL)
was added to la, b (0.01 mole) in DMF (20 mL).
The mixture was refluxed for 4 hr, decomposed
with saturated solution of hydrated sodium ace-
tate and filtered.
Preparation of the semicarbazone 3b. A diluted
ethanolic solution (1:1) of semicarbazide hydroch-
loride (0.02 mole) was added to an ethanolic so-
lution of 2b (0.02 mole) in ethanol (20 mL). The
mixture was acidified with acetic acid (0.5 mL)
dropwise at room temperature with stirring for 2
hr. The precipitate obtained was collected and
washed with water and crystallized.
Cyclization of the semicarbazone 3b. Prepara-
tion of 4b. An ethanolic solution of ferric chloride
hexahydrate (2 moles, 10 mL) was added to a so-
lution of sernicarbazone 3b (0.01 mole) in ethanol
(30 mL). The mixture was heated at 150°C for
few min and filtered after 24 hr. The solid so ob-
tained was washed and crystallized.
Table lII-Analgesic effect of tested compounds at one dose level as compared to control and aspirine treated groups of ma-
ture mice (n =5 mice) in seconds
Time*igr 15 min 30 min 45 min 60 min 75 min 90 rnin
Control AD 15.87 A 11.27 A 11.57 A 12.5 AE 11.67 AB 12.45
±0.78 ±0.45 ±0.398 ±0.43 ±0.49 ±0.61
Ib A 13.08 BE 20.25 B 17.75 BD 19.7 BC 18.7 B 11.8
±0.6 ±0.77 ±0.63 ±0.88 ±0.88 ±0.53
1a AD 15.5 BF 21.8 BD 19.97 B 20.91 CH 21.17 C 20.7
±0.76 ± 1.17 0.83 ±0.92 ± 1.08 ±0.88
3 C 22.3 C 49.95 C 25.3 AC 14.83 BDE 16.2 E 17.5
± 1.34 ±2.11 ± 1.23 ±0.70 ± 1.08 ±0.99
4 A 13.17 DE 17.5 D 15.7 DC 17.83 AFG 13.0 ABD 13.7
±O.95 ±0.56 ±0.67 ±0.48 ±0.58 ±0.56
Sa A 13.5 D 16.0 AD 12.83 AC 15.3 DEG 15.0 ADE 15.2
±0.85 ±0.68 ±0.97 ±0.84 ±0.82 ±0.79
5b B 35.83 C 47.45 C 26.17 C 16.0 DF 15.33 DE 16.42
±2.02 ±2.56 ±0.87 ±0.93 ±0.99 ± 1.13
6a A 14.0 D 15.5 AD 15.0 CE 16.5 BDE 16.5 ADE 14.7
±0.58 ± 1.02 ±0.93 ±0.75 ±0.72 ±0.88
6b A 13.17 D 16.7 D 15.5 AC 13.3 EF 14.5 ABD 14.5
±0.83 ±0.71 ±0.85 ±0.67 ±0.67 ±0.56
Sample "F" = 131.0586, Column = 120.1758, Interaction = 41.82549. P value 2E-89, 5E-57, 5E-86. F crit. = 1.917449,
2.407752,1.464418.
A, B, C, D, E, F: Means in each row not showing a COlJ1n1onletter differ significantly (P< 0.05).
"The time in the first raw of the table is the time of administration by minutes, while the figures in the table explained the time
of reaction on the hot plate by seconds.
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Preparation of chalcones Sa, b. To a solution
of 2 (0.01 mole) in ethanol (20 ml.), P:
aminoacetophenone (0.01 mole) and 10% NaOH
(10 mL) were added and the mixture was stirred
for 1 hr. The reaction mixture was refluxed for 3
hr, and neutralized with dil. HCl. The residue was
filtered off and crystallized.
Cyclization of chalcone Sa, b: Preparation of
6a, b. To a solution of 5 (0.03 mole) in methanol
(20 mL), a'b. excess of hydrazine hydrate was
added. The reaction mixture was refluxed for 3 hr
and the precipitate formed was filtered off and
crystallized.
Preparation of 2,3-diphenyl-5-chloro-l H-indole
717. JrChloroaniline hydrochloride (0.03 mole)
was fused with benzoin (0.03 mole). The reaction
mixture was acidified with cone. HCI and the so-
lid so obtained was crystallized.
Preparation of compound 8. A mixture of
cone. nitric and cone. sulphuric acid (1:1, 10 mL)
was added to 7 (1 gm, 0.003 mole) in portion of
2-3 ml during about 15 min, the reaction mixture
was shaken vigorously and the temperature not
allowed to raise above 60°C. The reaction was
heated on a boiling water-bath for 30 min, cooled
to room temperature and poured into 200 mL of
cold water. The nitro compound was filtered and
washed well with cold water. Cone, HCI (10 mL)
was added in small portions to a mixture of nitro
compound (1 g, 0.0028 mole) and granulated in
(3 g). The mixture was shaken vigorously and
heated under reflux at 100°C for about 1 hr. The
mixture was then cooled and made alkaline with
40% NaOH solution. The precipitate formed was
filtered off and crystallized.
Preparation of compound 9. A mixture of
compound 8 (0.003 mole) and salicylaldehyde (1
mL) was refluxed in dry benzene or pyridine (25
mL) for 4 hr on a water-bath. The precipitate
formed was filtered off and crystallized.
Preparation of compounds 10 and 12. Aceto-
nitrile or o-chlorophenol (3 mL) was added slow-
ly to a solution of 8 (0.01 mole) in dry DMF (50
ml), The reaction mixture was refJ.uxed for 1 hr
and left to cool. To the product so obtained was
added sodium hydride (1 g), and the reaction mix-
ture was refluxed for 1 hr and left to cool. The
reaction mixture was then treated with iced water
and the precipitate formed was filtered off and
crystallized.
Preparation of compound 11. To a solution of
8 (0.01 mole) in tetrahydrofuran (12 ml.), ethyl
isothiocyanate (2 mole) was added dropwise at
room temp. with stirring for 2 hr. The reaction
mixture was left for 3 days and the carbamate ob-
tained was cyclized by dissolving in dry DMF and
adding sodium hydride (1 g). The reaction mix-
ture was refluxed for 1 hr, left to cool and treated
with iced water. The precipitate obtained was
washed with water and crystallized.
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